All Richard Gonzalez articles

  • shutterstock_2397499071
    News

    AbbVie announces its new CEO

    2024-02-23T18:50:12Z

    During his tenure as AbbVie’s CEO, Richard Gonzalez successfully navigated the end of exclusivity for the biologic Humira in the US.

  • shutterstock_2017875503
    News

    AbbVie agrees $10 billion oncology acquisition

    2023-12-01T11:13:05Z

    Under its proposed acquisition of ImmunoGen, AbbVie will gain rights to ELAHERE®, the first antibody-drug conjugate (ADC) approved in ovarian cancer.